摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-二甲基-1H-吲唑-5-胺 | 945264-96-0

中文名称
N,N-二甲基-1H-吲唑-5-胺
中文别名
——
英文名称
N,N-dimethyl-1H-indazol-5-amine
英文别名
——
N,N-二甲基-1H-吲唑-5-胺化学式
CAS
945264-96-0
化学式
C9H11N3
mdl
——
分子量
161.206
InChiKey
QPQOPOUHRDMBLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    31.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存储条件:2-8°C,干燥密封。

反应信息

  • 作为反应物:
    描述:
    N,N-二甲基-1H-吲唑-5-胺1-(((2R,3S),2-(2,4-二氟苯基)-3-甲基环氧乙烷-2-基)甲基)-1H-1,2,4-三唑potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 (2R,3R)-2-(2,4-difluorophenyl)-3-[5-(dimethylamino)indazol-1-yl]-1-(1,2,4-triazol-1-yl)butan-2-ol
    参考文献:
    名称:
    Discovery of novel indazole-linked triazoles as antifungal agents
    摘要:
    The in vitro and in vivo activities of a series of (2R, 3R)-2-(2,4-difluorophenyl)-3-(substituted indazol-1-yl)-1-(1H-1,2,4-triazol- 1-yl)butan-2-ol as potential antifungal agents are described. In particular, the analog 12j having 5-bromo substitution on the indazole ring exhibited significant antifungal activity against a variety of fungal cultures (Candida spp. and Aspergillus spp.). In addition, oral administration of 12j showed its excellent efficacy against Candida albicans in a murine infection model and the significantly improved survival rates of the infected mice. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.03.074
  • 作为产物:
    描述:
    5-溴吲唑二甲胺 在 RuPhos palladacycle 、 lithium hexamethyldisilazane2-二环己基磷-2',6'-二异丙氧基-1,1'-联苯 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以96%的产率得到N,N-二甲基-1H-吲唑-5-胺
    参考文献:
    名称:
    用于杂环官能化的高效 Pd 催化胺化反应
    摘要:
    据报道,Pd 催化的未受保护的苯并稠合杂环的胺化作用使这类重要分子的修饰具有更大的灵活性和效率。这些简单而有效的程序的通用性通过多种结构类型的合成得到了证明。
    DOI:
    10.1021/ol101929v
点击查看最新优质反应信息

文献信息

  • COMBINATION OF KINASE INHIBITORS AND USES THEREOF
    申请人:INTELLIKINE, LLC
    公开号:US20150030588A1
    公开(公告)日:2015-01-29
    The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or a receptor tyrosine kinase (RTK) in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or an RTK in a subject. In yet another aspect, a method of inhibiting phosphorylation of Akt (S473) in a cell is set forth.
    本发明提供了一种治疗与PI3-激酶a和/或受体酪氨酸激酶(RTK)有关的疾病状况的方法。另一方面,该发明提供了一种治疗与PI3-激酶α和/或受体酪氨酸激酶(RTK)有关的疾病状况的方法。另一方面,提出了一种抑制细胞中Akt(S473)磷酸化的方法。
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    申请人:INFINITY PHARMACEUTICALS, INC.
    公开号:US20130267521A1
    公开(公告)日:2013-10-10
    Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    本发明描述了调节激酶活性的化合物和药物组合物,包括PI3激酶活性,以及用于治疗与激酶活性相关的疾病和状况的化合物、药物组合物和方法,包括PI3激酶活性。
  • [EN] HETEROCYCLIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
    申请人:INTELLIKINE LLC
    公开号:WO2013078441A1
    公开(公告)日:2013-05-30
    Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    本文描述了调节PI3激酶活性的杂环实体,含有这些杂环实体的药物组合物,以及使用这些化学实体治疗与PI3激酶活性相关的疾病和症状的方法。
  • Antifungal Triazole Derivatives
    申请人:Park Joon Seok
    公开号:US20080194661A1
    公开(公告)日:2008-08-14
    Disclosed herein are antifungal triazole derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same.
    本文揭示了抗真菌三唑衍生物或其药用盐,其制备方法,以及包含它们的药物组合物。
  • Catalyst for producing arylamine and process for producing arylamine by means thereof
    申请人:Miyazaki Takanori
    公开号:US20070282111A1
    公开(公告)日:2007-12-06
    To provide a process for preparing an arylamine highly selectively and highly efficiently, which is also industrially superior without a fear of a side reaction when a strong base is employed. An aryl compound having an active group is reacted with an amine compound in the presence of a base by means of a catalyst for producing an arylamine which comprises a palladium compound having a tertiary phosphine group and a phase-transfer catalyst.
    提供一种高度选择性和高效率地制备芳胺的工艺,同时在使用强碱时无需担心副反应的工业上优越的方法。在存在碱和催化剂的情况下,通过将具有活性基团的芳基化合物与胺基化合物反应,制备一种包含具有三膦基团和相转移催化剂的化合物的芳胺。
查看更多